Terms: = Liver cancer AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP AND Staging
15 results:
1. Prognostic influence of multiple hepatic lesions in resectable intrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
Jansson H; Villard C; Nooijen LE; Ghorbani P; Erdmann JI; Sparrelid E
Eur J Surg Oncol; 2023 Apr; 49(4):688-699. PubMed ID: 36710214
[TBL] [Abstract] [Full Text] [Related]
2. Pathologic complete response following FOLFIRINOX and olaparib treatment for hepatic metastasized pancreatic ductal adenocarcinoma with a germline BRCA mutation.
Okada K; Uemura K; Okamoto W; Sumiyoshi T; Shintakuya R; Otsuka H; Serikawa M; Ishii Y; Arihiro K; Takahashi S
Clin J Gastroenterol; 2023 Apr; 16(2):283-288. PubMed ID: 36574187
[TBL] [Abstract] [Full Text] [Related]
3. Systematic review and meta-analysis of survival outcomes in T2a and T2b gallbladder cancers.
Alrawashdeh W; Kamarajah SK; Gujjuri RR; Cambridge WA; Shrikhande SV; Wei AC; Abu Hilal M; White SA; Pandanaboyana S
HPB (Oxford); 2022 Jun; 24(6):789-796. PubMed ID: 35042673
[TBL] [Abstract] [Full Text] [Related]
4. [Ductal adenocarcinoma of the pancreas: subtypes and molecular pathology].
Schlitter AM; Konukiewitz B; Kasajima A; Reichert M; Klöppel G
Pathologe; 2021 Sep; 42(5):464-471. PubMed ID: 34402977
[TBL] [Abstract] [Full Text] [Related]
5. Circulatory miR-221 & miR-542 expression profiles as potential molecular biomarkers in Hepatitis C Virus mediated liver cirrhosis and hepatocellular carcinoma.
Yasser MB; Abdellatif M; Emad E; Jafer A; Ahmed S; Nageb L; Abdelshafy H; Al-Anany AM; Al-Arab MAE; Gibriel AA
Virus Res; 2021 Apr; 296():198341. PubMed ID: 33607184
[TBL] [Abstract] [Full Text] [Related]
6. Patients presenting with metastases: stage IV uveal melanoma, an international study.
Garg G; Finger PT; Kivelä TT; Simpson ER; Gallie BL; Saakyan S; Amiryan AG; Valskiy V; Chin KJ; Semenova E; Seregard S; Filì M; Wilson M; Haik B; Caminal JM; Catala-Mora J; Gutiérrez C; Pelayes DE; Folgar AM; Jager MJ; Doğrusöz M; Luyten GPM; Singh AD; Suzuki S;
Br J Ophthalmol; 2022 Apr; 106(4):510-517. PubMed ID: 33452185
[TBL] [Abstract] [Full Text] [Related]
7. Development and validation of a web-based calculator to predict individualized conditional risk of site-specific recurrence in nasopharyngeal carcinoma: Analysis of 10,058 endemic cases.
Wu CF; Lv JW; Lin L; Mao YP; Deng B; Zheng WH; Wen DW; Chen Y; Kou J; Chen FP; Yang XL; Zheng ZQ; Li ZX; Xu SS; Ma J; Sun Y
Cancer Commun (Lond); 2021 Jan; 41(1):37-50. PubMed ID: 33270990
[TBL] [Abstract] [Full Text] [Related]
8. Nomograms to predict survival outcomes after microwave ablation in elderly patients (>65 years old) with early-stage hepatocellular carcinoma.
Huang Z; Gu Y; Zhang T; Wu S; Wang X; An C; Huang J
Int J Hyperthermia; 2020; 37(1):808-818. PubMed ID: 32619374
[No Abstract] [Full Text] [Related]
9. Use of a novel index, the A-index, and its associated nomogram to predict overall survival rates after resection of primary hepatocellular carcinoma.
Cai BB; Hou XQ; Zhou X; Ye TT; Fang G; Huang HZ; Bao XD; Wang WM
Clin Chim Acta; 2020 Jan; 500():34-41. PubMed ID: 31655054
[TBL] [Abstract] [Full Text] [Related]
10. A four-methylated mRNA signature-based risk score system predicts survival in patients with hepatocellular carcinoma.
Wang Y; Ruan Z; Yu S; Tian T; Liang X; Jing L; Li W; Wang X; Xiang L; Claret FX; Nan K; Guo H
Aging (Albany NY); 2019 Jan; 11(1):160-173. PubMed ID: 30631005
[TBL] [Abstract] [Full Text] [Related]
11. A novel, non-invasive model for diagnosing liver fibrosis stage in patients with hepatocellular carcinoma.
Ouyang GX; Zhang YM; Zhu SL; Wang P; Ren Y; Li JH; Liu YK; Chen J; Xiang BD; Li LQ; Liu JY; Zhang ZM
Sci Rep; 2018 Aug; 8(1):13074. PubMed ID: 30166568
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
[TBL] [Abstract] [Full Text] [Related]
13. Nomogram based on tumor-associated neutrophil-to-lymphocyte ratio to predict survival of patients with gastric neuroendocrine neoplasms.
Cao LL; Lu J; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Chen QY; Lin M; Tu RH; Huang CM
World J Gastroenterol; 2017 Dec; 23(47):8376-8386. PubMed ID: 29307997
[TBL] [Abstract] [Full Text] [Related]
14. Morphologic severity of cirrhosis determines the extent of liver resection in patients with hepatocellular carcinoma and Child-Pugh grade A cirrhosis.
Zhou SJ; Zhang EL; Liang BY; Zhang ZY; Dong KS; Hou P; Chen XP; Xiong M; Huang ZY
J Surg Res; 2016 Feb; 200(2):444-51. PubMed ID: 26470819
[TBL] [Abstract] [Full Text] [Related]
15. [Experience of radiofrequency ablation on liver malignancies: a report of 803 cases].
Chen MS; Zhang YJ; Li JQ; Liang HH; Zhang YQ; Lin XJ; Zheng Y; Xu L; Wan YL
Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(21):1469-71. PubMed ID: 18275711
[TBL] [Abstract] [Full Text] [Related]
